MedTrace Logo

Pancreatic Exocrine Insufficiency in Acute Pancreatitis

NCT02563080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-08-16

No results posted yet for this study

Summary

Severe pancreatitis induces more damage in the pancreas and might therefore result reduced exocrine function leading to the insufficiency. The aim of this prospective study is to investigate development of pancreatic exocrine insufficiency in patients recovering from first attack of moderately severe or severe acute pancreatitis.

Conditions

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Leena Kylänpää, MD,PhD · Helsinki University Central Hospital

  • Outi Lindström, Md,PhD · Helsinki University Central Hospital

  • Taija Korpela, MD · Helsinki University Central Hospital

  • Marianne Udd, MD,PhD · Helsinki University Central Hospital

  • Panu Mentula, MD,PhD · Helsinki University Central Hospital

  • Päivi Siironen, MD,PhD · Helsinki University Central Hospital

  • Matti Tolonen, MD · Helsinki University Central Hospital

  • Elina Lietzen, MD · Turku University Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02563080 on ClinicalTrials.gov